These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14150250)

  • 1. VASCULAR RELATIONSHIPS OF TUMOR AND HOST.
    DAY ED
    Prog Exp Tumor Res; 1964; 4():57-97. PubMed ID: 14150250
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the exchange of fluids between host and tumor. III. Regulation of blood flow in hepatomas and other rat tumors.
    GULLINO PM; GRANTHAM FH
    J Natl Cancer Inst; 1962 Jan; 28():211-29. PubMed ID: 13902917
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis on anti-hepatoma effect of medicine invigorating blood circulation and eliminating blood stasis based on warm-pungent-liver efficiency network].
    Gu H; Ma L; Yuan B; Zhang YL; Wang Y; Qiao YJ
    Zhongguo Zhong Yao Za Zhi; 2014 Jul; 39(13):2417-21. PubMed ID: 25276956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BLOOD FLOW AND VASCULAR STROMA OF TUMORS.
    GULLINO PM
    Acta Unio Int Contra Cancrum; 1964; 20():1645-6. PubMed ID: 14242985
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE SPECTRUM OF ANTI-HEPATOMA AGENTS].
    SATO H
    Saishin Igaku; 1965 Apr; 20():1000-3. PubMed ID: 14317153
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative studies on the developing vascular system of rat hepatoma.
    Yamaura H; Sato H
    J Natl Cancer Inst; 1974 Nov; 53(5):1229-40. PubMed ID: 4372377
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances of studies on mechanisms of drugs for activating blood circulation and removing blood stasis in treatment of primary liver cancer.
    Ren R; Ju L; Chen Z
    J Tradit Chin Med; 2005 Dec; 25(4):304-9. PubMed ID: 16447677
    [No Abstract]   [Full Text] [Related]  

  • 8. Metastasis and chemotherapy.
    YOSHIDA T
    Acta Unio Int Contra Cancrum; 1960; 16():496-9. PubMed ID: 13846577
    [No Abstract]   [Full Text] [Related]  

  • 9. [STUDIES ON THE DIFFERENCES IN THE ACTIVITY OF VARIOUS TUMOR-CONTROLLING AGENTS ON ASCITES HEPATOMA CELL LINES].
    SAKURAI Y; TSUKAKOSHI S
    Saishin Igaku; 1965 Apr; 20():996-1000. PubMed ID: 14317194
    [No Abstract]   [Full Text] [Related]  

  • 10. The mobilization, recruitment and contribution of bone marrow-derived endothelial progenitor cells to the tumor neovascularization occur at an early stage and throughout the entire process of hepatocellular carcinoma growth.
    Zhu H; Shao Q; Sun X; Deng Z; Yuan X; Yu D; Zhou X; Ding Y
    Oncol Rep; 2012 Oct; 28(4):1217-24. PubMed ID: 22858892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased angiotensin II receptors mediate decreased vascular response in hepatocellular cancer.
    Wu Y; Cahill PA; Sitzmann JV
    Ann Surg; 1996 Feb; 223(2):225-31. PubMed ID: 8597519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vascular elasticity in patients with spontaneous rupture of hepatocellular carcinoma].
    Zhu L; Geng X; Fan S
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):96. PubMed ID: 11983121
    [No Abstract]   [Full Text] [Related]  

  • 13. Interobserver and intraobserver variability in evaluating vascular invasion in hepatocellular carcinoma.
    Fan L; Mac MT; Frishberg DP; Fan X; Dhall D; Balzer BL; Geller SA; Wang HL
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1556-61. PubMed ID: 20796155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible associations between ascites and vascular invasion in patients with hepatocellular carcinoma.
    Deng L; Qin HG; Yang C; Zhong JH
    Tumour Biol; 2015 Jul; 36(7):4933-4. PubMed ID: 25934340
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spectrum of antineoplastic agents in ascites hepatoma--hypothesis on application of the results of animal experiments to human cancer in screening of antineoplastic agents].
    Sato H; Ichimura H
    Nihon Rinsho; 1971 Jul; 29(7):1818-26. PubMed ID: 4338289
    [No Abstract]   [Full Text] [Related]  

  • 16. Real-time ultrasonographic demonstration of vascular invasion by hepatocellular carcinoma.
    Jackson VP; Martin-Simmerman P; Becker GJ; Holden RW
    J Ultrasound Med; 1983 Jun; 2(6):277-80. PubMed ID: 6308282
    [No Abstract]   [Full Text] [Related]  

  • 17. RF-assisted gadofullerene nanoparticles induces rapid tumor vascular disruption by down-expression of tumor vascular endothelial cadherin.
    Li X; Zhen M; Deng R; Yu T; Li J; Zhang Y; Zou T; Zhou Y; Lu Z; Guan M; Xu H; Shu C; Wang C
    Biomaterials; 2018 May; 163():142-153. PubMed ID: 29459323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HEPATOMA IN A SMALL CHILD].
    NAGASU K
    Chiryo; 1964 Jan; 46():169-72. PubMed ID: 14110961
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant hepatoma.
    van Dyk JJ
    Proc Mine Med Off Assoc SA; 1975; 55(421):19-20. PubMed ID: 209446
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: Hepatoma: a challenging disease.
    Umsawasdi T
    J Med Assoc Thai; 1976 Mar; 59(3):95-9. PubMed ID: 177711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.